CANNAPHARMARX, INC. Income Statement
CPMD|11 years of annual SEC 10-K data (FY2014-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 11 fiscal years. All figures from audited SEC 10-K filings.
CANNAPHARMARX, INC. reported $1M in revenue and $11M in net loss for FY2025. Revenue increased 66.1% from FY2024 to FY2025.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -18.28 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.4M | $820.1K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Cost of Revenue | $3.4M | $3.8M | - | - | - | - | - | - | - | - | - |
| Gross Profit | -$2.1M | -$2.9M | - | - | - | - | - | - | - | - | - |
| SG&A Expense | $489.6K | $116.6K | $2.2M | $852.6K | $2.1M | $477.9K | $8.8K | $6.6K | $276.8K | $4.2M | $425.5K |
| R&D Expense | - | - | - | - | - | - | - | - | - | - | $324.1K |
| Operating Income | -$3.3M | -$3.6M | -$5.2M | -$3.0M | -$14.5M | -$16.0M | -$954.3K | -$6.6K | -$1.0M | -$11.7M | -$4.0M |
| Interest Expense | $2.0M | $2.3M | $2.3M | $1.5M | $2.3M | $4.5M | $2.1M | $0 | $423 | $2.7K | $5.0K |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$11.1M | -$9.9M | -$8.5M | -$8.8M | -$19.9M | -$20.5M | -$3.1M | -$6.6K | -$1.0M | -$11.7M | -$4.0M |
| EPS (Basic) | - | - | $0.12 | - | - | - | - | - | - | - | - |
| EPS (Diluted) | -$0.02 | $0.01 | $0.12 | - | -$0.66 | -$0.17 | $0.00 | -$0.06 | -$0.77 | -$0.36 | -$0.04 |
| Shares Outstanding | 662.5M | 440.8M | 125.5M | 47.0M | 36.5M | 18.9M | 18.0M | 18.0M | 18.0M | 17.4M | 2.4M |
| Gross Margin | -153.1% | -357.9% | - | - | - | - | - | - | - | - | - |
| Operating Margin | -245.8% | -442.7% | - | - | - | - | - | - | - | - | - |
| Profit Margin | -817.2% | -1207.8% | - | - | - | - | - | - | - | - | - |